BindingDB Entry 50032319: Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation.

BindingDB

Description

No description available.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.3

FAIR Score

52%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

BindingDB

License

Attribution 3.0 United States

Assigned Domain

Subfield

Oncology

Field

Medicine

Domain

Health Sciences

Confidence Score

66%

Source

Scholar Data Model

Keywords

Epidermal growth factor receptor, Epidermal growth factor receptor and ErbB2 (HER1 and HER2), Fibroblast growth factor receptor 1, Focal adhesion kinase 1/vascular endothelial growth factor receptor 3, Glycogen synthase kinase-3, Insulin receptor, Insulin-like growth factor I receptor, Mitogen-activated protein kinase 3, Platelet-derived growth factor receptor, Platelet-derived growth factor receptor beta, Protein kinase C theta type, RAF serine/threonine protein kinase, Serine/threonine-protein kinase Aurora, Tyrosine-protein kinase Kit (Kit), VEGF-receptor 2 and tyrosine-protein kinase SRC, Vascular endothelial growth factor receptor, Vascular endothelial growth factor receptor 2, and Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2), Takeda Pharmaceutical Co., Ltd, Affinity

Normalization Factors

FT

51.92

CTw

1.00

MTw

1.00